相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy Volunteers
Jeremy J. Lim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4
Kelly L. Warfield et al.
ANTIVIRAL RESEARCH (2016)
Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes
Nicole L. Kallewaard et al.
CELL (2016)
The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design
Annelies Stevaert et al.
MEDICINAL RESEARCH REVIEWS (2016)
The Iminosugar UV-4 is a Broad Inhibitor of Influenza A and B Viruses ex Vivo and in Mice
Kelly L. Warfield et al.
VIRUSES-BASEL (2016)
Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients
Cynthia Sung et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases-Not Glycolipid Processing Enzymes
Andrew C. Sayce et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Phase 1 clinical trials of DAS181, an inhaled sialidase, in healthy adults
Jonathan M. Zenilman et al.
ANTIVIRAL RESEARCH (2015)
Dengue Virus Evolution under a Host-Targeted Antiviral
Emily Plummer et al.
JOURNAL OF VIROLOGY (2015)
Advancements in the development of subunit influenza vaccines
Naru Zhang et al.
MICROBES AND INFECTION (2015)
A broadly neutralizing human monoclonal antibody is effective against H7N9
Kannan Tharakaraman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Glycan regulation of ER-associated degradation through compartmentalization
Ron Benyair et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue)
Kelly L. Warfield et al.
VIRUSES-BASEL (2015)
Strain-specific antiviral activity of iminosugars against human influenza A viruses
S. Hussain et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Efficacy and Safety of Treatment With an Anti-M2e Monoclonal Antibody in Experimental Human Influenza
Eleanor L. Ramos et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
In Vivo Therapeutic Protection against Influenza A (H1N1) Oseltamivir-Sensitive and Resistant Viruses by the Iminosugar UV-4
Eric J. Stavale et al.
PLOS ONE (2015)
Nitazoxanide: A first-in-class broad-spectrum antiviral agent
Jean-Francois Rossignol
ANTIVIRAL RESEARCH (2014)
Arbidol as a broad-spectrum antiviral: An update
Julie Blaising et al.
ANTIVIRAL RESEARCH (2014)
Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2
Michael P. Clark et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Antiviral combinations for severe influenza
Jake Dunning et al.
LANCET INFECTIOUS DISEASES (2014)
Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial
Jenny G. Low et al.
LANCET INFECTIOUS DISEASES (2014)
Playing Hide and Seek: How Glycosylation of the Influenza Virus Hemagglutinin Can Modulate the Immune Response to Infection
Michelle D. Tate et al.
VIRUSES-BASEL (2014)
Mechanisms of Action and Efficacy of Statins against Influenza
Parvaneh Mehrbod et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Amantadine and rimantadine for influenza A in children and the elderly
Marcia G. Alves Galvao et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
The use of sialidase therapy for respiratory viral infections
John M. Nicholls et al.
ANTIVIRAL RESEARCH (2013)
An iminosugar with potent inhibition of dengue virus infection in vivo
Stuart T. Perry et al.
ANTIVIRAL RESEARCH (2013)
Favipiravir (T-705), a novel viral RNA polymerase inhibitor
Yousuke Furuta et al.
ANTIVIRAL RESEARCH (2013)
Antiviral therapies targeting host ER alpha-glucosidases: Current status and future directions
Jinhong Chang et al.
ANTIVIRAL RESEARCH (2013)
Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses
Jinhong Chang et al.
ANTIVIRAL RESEARCH (2013)
An In Vivo Human-Plasmablast Enrichment Technique Allows Rapid Identification of Therapeutic Influenza A Antibodies
Gerald Nakamura et al.
CELL HOST & MICROBE (2013)
Hyperimmune IV Immunoglobulin Treatment A Multicenter Double-Blind Randomized Controlled Trial for Patients With Severe 2009 Influenza A(H1N1) Infection
Ivan F. N. Hung et al.
CHEST (2013)
Adjunctive therapies and immunomodulating agents for severe influenza
David S. C. Hui et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
Low-dose oral interferon alpha as prophylaxis against viral respiratory illness: a double-blind, parallel controlled trial during an influenza pandemic year
Alayne L. Bennett et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
Protective effect of homonojirimycin from Commelina communis (dayflower) on influenza virus infection in mice
Guo-bin Zhang et al.
PHYTOMEDICINE (2013)
Homonojirimycin, an alkaloid from dayflower inhibits the growth of influenza A virus in vitro
G. -B. Zhang et al.
ACTA VIROLOGICA (2013)
Macrolide Therapy in Respiratory Viral Infections
Jin-Young Min et al.
MEDIATORS OF INFLAMMATION (2012)
The Evolutionary Pattern of Glycosylation Sites in Influenza Virus (H5N1) Hemagglutinin and Neuraminidase
Wentian Chen et al.
PLOS ONE (2012)
Competitive inhibitor of cellular α-glucosidases protects mice from lethal dengue virus infection
Jinhong Chang et al.
ANTIVIRAL RESEARCH (2011)
Iminosugars as therapeutic agents: recent advances and promising trends
Robert J. Nash et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Glycosylation Site Alteration in the Evolution of Influenza A (H1N1) Viruses
Shisheng Sun et al.
PLOS ONE (2011)
Host shifts and molecular evolution of H7 avian influenza virus hemagglutinin
Camille Lebarbenchon et al.
VIROLOGY JOURNAL (2011)
Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins
Steven J. Gamblin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Biochemical Characterization of Enzyme Fidelity of Influenza A Virus RNA Polymerase Complex
Shilpa Aggarwal et al.
PLOS ONE (2010)
Gene Expression Signature-Based Screening Identifies New Broadly Effective Influenza A Antivirals
Laurence Josset et al.
PLOS ONE (2010)
UDP-GlC:glycoprotein glucosyltransferase-glucosidase II, the ying-yang of the ER quality control
Cecilia D'Alessio et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Targeting a host process as an antiviral approach against dengue virus
Andrew C. Sayce et al.
TRENDS IN MICROBIOLOGY (2010)
CS-8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus Activity
Makoto Yamashita et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Active 1918 pandemic flu viral neuraminidase has distinct N-glycan profile and is resistant to trypsin digestion
Zhengliang L. Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Antiviral Role of Toll-Like Receptor-3 Agonists Against Seasonal and Avian Influenza Viruses
J. P. Wong et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Thiazolides, a New Class of Anti-influenza Molecules Targeting Viral Hemagglutinin at the Post-translational Level
Jean Francois Rossignol et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery
Stephanie Pollock et al.
AIDS (2008)
Glucosylated free oligosaccharides are biomarkers of endoplasmicreticulum α-glucosidase inhibition
Dominic S. Alonzi et al.
BIOCHEMICAL JOURNAL (2008)
The Cotranslational Maturation Program for the Type II Membrane Glycoprotein Influenza Neuraminidase
Ning Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus
Bo-Jian Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Treatment with convalescent plasma for influenza A (H5N1) infection
Boping Zhou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Virus glycosylation: role in virulence and immune interactions
David J. Vigerust et al.
TRENDS IN MICROBIOLOGY (2007)
Meta-analysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment?
Thomas C. Luke et al.
ANNALS OF INTERNAL MEDICINE (2006)
Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection
MP Malakhov et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Antiviral effect of α-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles
C Chapel et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesis
HR Mellor et al.
BIOCHEMICAL JOURNAL (2004)
Cellular effects of deoxynojirimycin analogues: inhibition of N-linked oligosaccharide processing and generation of free glucosylated oligosaccharides
HR Mellor et al.
BIOCHEMICAL JOURNAL (2004)
The effect of losing glycosylation sites near the receptor-binding region on the receptor phenotype of the human influenza virus H1N1
VP Marinina et al.
MOLECULAR BIOLOGY (2003)
N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin
R Daniels et al.
MOLECULAR CELL (2003)
Functional balance between haemagglutinin and neuraminidase in influenza virus infections
R Wagner et al.
REVIEWS IN MEDICAL VIROLOGY (2002)
Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule
E Tsuchiya et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Antiviral effects of an iminosugar derivative on flavivirus infections
SF Wu et al.
JOURNAL OF VIROLOGY (2002)
In vitro and in vivo activities of anti-influenza virus compound T-705
Y Furuta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Targeting glycosylation as a therapeutic approach
RA Dwek et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus
D Durantel et al.
JOURNAL OF VIROLOGY (2001)
BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design
YS Babu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Folding of viral envelope glycoproteins in the endoplasmic reticulum
I Braakman et al.
TRAFFIC (2000)
Influenza virus infection of desialylated cells
SJ Stray et al.
GLYCOBIOLOGY (2000)
Effect of glycosylation and glucose trimming inhibitors on the influenza A virus glycoproteins
T Saito et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2000)
N-butyldeoxygalactonojirimycin:: A more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo
U Andersson et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Glucosidase and mannosidase inhibitors mediate increased secretion of mutant α1 antitrypsin Z
NY Marcus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals
M Matrosovich et al.
JOURNAL OF VIROLOGY (2000)
Truncated N-glycans affect protein folding in the ER of CHO-derived mutant cell lines without preventing calnexin binding
M Ermonval et al.
GLYCOBIOLOGY (2000)
分享论文
